Menu Search
Equities

Dominari Holdings Inc

DOMH:NAQ

Dominari Holdings Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.61
  • Today's Change-0.02 / -1.23%
  • Shares traded4.51k
  • 1 Year change-21.95%
  • Beta0.9732
Data delayed at least 15 minutes, as of Nov 22 2024 19:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Dominari Holdings Inc had net income fall 3.51% from a loss of 22.11m to a larger loss of 22.88m despite a -- increase in revenues from 0.00 to 2.04m.
Gross margin--
Net profit margin-180.22%
Operating margin-115.85%
Return on assets-42.55%
Return on equity-46.97%
Return on investment-44.27%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Dominari Holdings Inc fell by 30.34m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 22.23m for operations while cash used for investing totalled 7.17m.
Cash flow per share-3.79
Price/Cash flow per share--
Book value per share6.10
Tangible book value per share6.10
More ▼

Balance sheet in USDView more

Dominari Holdings Inc uses little or no debt in its capital structure.
Current ratio10.25
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.